GERRIANN MEANDRO: Open Payments
NPI 1740350016 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$931 in 34 payments from 21 companies in 2025. Trend: 2023 $125 · 2024 $1,145 · 2025 $931
Food & beverage: $931
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $155 |
| Incyte Corporation | 2 | $141 |
| Janssen Biotech, Inc. | 4 | $85 |
| Merck Sharp & Dohme LLC | 3 | $75 |
| PFIZER INC. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| Celgene Corporation | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| TAIHO ONCOLOGY, INC. | 1 | $33 |
Products named: WAYRILZ, Jakafi, IMFINZI, RYBREVANT, KEYTRUDA, IBRANCE, OPDUALAG, PLUVICTO.
Industry payments across FL — which companies pay providers there.
